Clinical Trials Logo
  1. Home
  2. Peyronie's Disease
  3. NCT05873595

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease — CURVE-PD  

Peyronie's Disease Clinical Trial

Official title:
Clinical Understanding Through Real-world Data to Validate Effectiveness of Treatments in Peyronie's Disease

Clinical Trial Summary

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.

Clinical Trial Description

Each participant of the study will have their data collected from the date of confirmed diagnosis of PD to the date of enrollment in the registry, post consent. Data will be collected from the participant's clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05873595
Study type Observational [Patient Registry]
Source Endo Pharmaceuticals
Contact
Status Terminated
Phase
Start date June 20, 2023
Completion date February 26, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01685437 - A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease Phase 3
Completed NCT01430169 - Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease Phase 2
Completed NCT01221597 - Study of AA4500 in the Treatment of Peyronie's Disease Phase 3
Recruiting NCT05108558 - Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders Phase 4
Recruiting NCT05147779 - Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis Phase 1
Recruiting NCT03767452 - Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response Phase 4
Completed NCT02267460 - An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease Phase 3
Completed NCT01221623 - Study of AA4500 in the Treatment of Peyronie's Disease Phase 3
Completed NCT02298829 - Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
Completed NCT01243411 - A Study of AA4500 in Men With Peyronie's Disease Phase 3
Completed NCT01578473 - Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease Phase 1
Not yet recruiting NCT05855070 - Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease N/A
Completed NCT02072018 - Peyronie's Disease Treatment Protocol Phase 1
Active, not recruiting NCT04786106 - Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's Phase 4
Completed NCT00812838 - H-22411: BOTOX® for Peyronie's Disease Phase 2
Completed NCT02395029 - Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD Phase 1
Completed NCT00755222 - The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease Phase 2